Dyne Therapeutics Inc — Stato Patrimoniale (NASDAQ:DYN) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 353.33 M425.66 M306.32 M165.08 M691.23 M1.19 B Totale passività 10.97 M57.47 M53.96 M73.79 M61.4 M214.83 M Patrimonio netto totale 342.37 M368.2 M252.36 M91.29 M629.84 M972.13 M Totale passività e patrimonio netto 353.33 M425.66 M306.32 M165.08 M691.23 M1.19 B Debito totale —————169.2 M Indebitamento netto —————-941.36 M

Notizie

Raymond James conferma Strong Buy su Dyne Therapeutics

Jefferies reiterates Buy on BioMarin stock after DMD trial data

Micron and Palantir among market cap stock movers on Tuesday

Dyne Therapeutics, Inc. (DYN) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks Transcript

Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN)

Baird conferma il rating su Dyne Therapeutics per i progressi negli studi clinici

Baird reiterates Dyne Therapeutics stock rating on trial progress

Jones Trading conferma Buy su Dyne Therapeutics dopo aggiornamenti su DMD e DM1

Jones Trading reiterates Buy on Dyne Therapeutics stock after DMD, DM1 updates

Stifel conferma il rating su Dyne Therapeutics dopo il design dello studio

Stifel reiterates Dyne Therapeutics stock rating on trial design

Le azioni Dyne appaiono più solide dopo i dati sulla distrofia muscolare, secondo Jones